IVF After 40: Success Factors, Egg Quality and Treatment Options

More women than ever are considering pregnancy in their 40s. For some, this is the first time they have tried to conceive. Others may already have experienced unsuccessful attempts at natural conception or previous IVF cycles.

One of the first questions is usually:

“Can IVF work after 40?”

The answer is yes—IVF after 40 can result in pregnancy and the birth of a healthy baby—but age significantly affects reproductive potential, particularly when a woman is using her own eggs.

At this stage of reproductive life, understanding ovarian reserve, egg quality, embryo development and the available treatment options becomes especially important.

Rather than focusing solely on age or a single laboratory result, an individualized fertility assessment can help determine which treatment strategy is most appropriate for each woman.

Why Does Fertility Decline After 40?

Female fertility naturally declines with age.

Women are born with a finite number of eggs, and both the number of remaining eggs and their reproductive potential decrease throughout reproductive life.

By the age of 40, two factors become particularly important:

Egg quantity – fewer follicles and eggs generally remain available.

Egg quality – a larger proportion of the remaining eggs may have chromosomal abnormalities that can affect fertilization, embryo development, implantation and pregnancy.

This is why age is such an important factor when assessing fertility and planning IVF.

However, chronological age alone does not provide the complete picture. Two women of the same age can have very different ovarian reserves, medical histories and previous responses to fertility treatment.

Can You Have IVF After 40?

Yes.

Women over 40 regularly undergo in vitro fertilization (IVF), but treatment needs to be planned according to their individual reproductive circumstances.

The first step is usually a comprehensive fertility assessment.

This may include evaluation of:

• Anti-Müllerian Hormone (AMH)
• Antral Follicle Count (AFC)
• FSH and estradiol
• Menstrual and reproductive history
• Previous pregnancies
• Previous IVF cycles and ovarian response
• Uterine and endometrial health
• Fallopian tubes where clinically relevant
• General medical health
• Sperm quality of the male partner

The objective is not simply to determine whether IVF is possible, but to understand which IVF strategy provides the most appropriate option for that particular patient.

IVF Success After 40: Why Individual Assessment Matters

There is no single IVF success rate that applies to every woman over 40.

Success depends on several factors, including:

• Exact age
• Whether the patient’s own eggs or donor eggs are being used
• Ovarian reserve
• Number of eggs retrieved
• Egg quality
• Fertilization
• Embryo development
• Sperm quality
• Uterine health
• Previous reproductive history
• Underlying causes of infertility

This is why online IVF percentages need to be interpreted carefully.

A population-level statistic cannot tell an individual woman exactly what her chances of having a baby will be.

Egg Quality After 40

Egg quality becomes one of the most important considerations in IVF after 40.

As reproductive age advances, chromosomal abnormalities in oocytes become more common.

An egg may still mature and fertilize, but the resulting embryo may not necessarily have the chromosomal potential required for normal development.

This can contribute to:

• Lower implantation rates
• Failure of embryos to develop normally
• Unsuccessful IVF cycles
• Increased risk of miscarriage

This does not mean that all eggs after 40 are abnormal.

It means that the probability of obtaining a chromosomally competent egg generally decreases with age.

Consequently, the number of eggs available can become particularly important: retrieving more eggs may provide more opportunities to obtain an embryo capable of successful development, although there is never a guarantee.

Ovarian Reserve After 40: AMH and AFC

Two measurements frequently used when planning IVF are AMH (Anti-Müllerian Hormone) and AFC (Antral Follicle Count).

AMH and AFC provide information about ovarian reserve and can help predict how the ovaries may respond to fertility medication.

A woman with a relatively higher ovarian reserve may potentially produce more follicles during ovarian stimulation, whereas a woman with diminished ovarian reserve may produce fewer eggs.

However, there is an important distinction:

AMH and AFC primarily help estimate egg quantity and ovarian response. They do not directly measure egg quality.

Age therefore remains extremely important even when AMH appears reassuring.

Similarly, a very low AMH result should not automatically be interpreted as meaning that pregnancy is impossible.

IVF with Your Own Eggs After 40

For many women, the first preference is to attempt IVF using their own eggs.

Whether this is a reasonable strategy depends on the individual situation.

Factors such as age, AMH, AFC, previous ovarian response and previous embryo development can help the fertility specialist assess whether another attempt using the patient’s own eggs may be appropriate.

For some women, obtaining only a small number of eggs does not necessarily mean treatment should not proceed.

However, expectations should be realistic.

As age increases—particularly during the early-to-mid 40s—the probability of obtaining a chromosomally competent embryo using one’s own eggs generally decreases.

The decision should therefore be individualized rather than based on age alone.

What If You Have Low AMH After 40?

Having both advanced reproductive age and low AMH can make IVF more challenging because two different factors may be involved simultaneously.

Low AMH may indicate that fewer eggs are likely to be obtained during ovarian stimulation.

Age may independently affect the reproductive potential of those eggs.

However, AMH should not be treated as a simple “fertility score.”

A low AMH result cannot determine by itself whether an individual egg can produce a healthy embryo.

The patient’s complete reproductive profile and previous treatment history are much more informative when developing an IVF strategy.

Can IVF Stimulation Be Personalized After 40?

Yes. Personalization is particularly important for women with diminished ovarian reserve or previous poor response.

The ovarian stimulation protocol can be selected according to factors such as:

• Age
• AMH and AFC
• Previous response to stimulation
• Number of eggs previously retrieved
• Hormonal profile
• Previous embryo development
• General medical history

The objective is to achieve an appropriate ovarian response while avoiding the assumption that simply increasing medication doses will necessarily produce more or better-quality eggs.

Every patient responds differently, which is why previous IVF cycles can provide valuable information when planning subsequent treatment.

What Is ICSI and Is It Always Needed After 40?

Intracytoplasmic Sperm Injection (ICSI) involves injecting a single sperm directly into an egg.

ICSI is particularly useful for certain forms of male-factor infertility and in other selected clinical circumstances.

However, age alone does not automatically mean that ICSI is necessary.

The choice between conventional IVF fertilization and ICSI should be based on the couple’s individual circumstances, including semen parameters, previous fertilization history and the treatment strategy recommended by the fertility team.

Embryo Development After 40

Egg retrieval is only one stage of IVF.

After fertilization, the laboratory monitors embryo development over the following days.

Some embryos stop developing before reaching the blastocyst stage. Others develop successfully but may still have chromosomal abnormalities.

Because age affects the probability of chromosomal abnormalities, embryo development and selection become particularly important components of IVF treatment after 40.

High-quality embryology laboratory conditions and individualized decisions regarding embryo culture and transfer are therefore essential elements of treatment.

What About PGT-A?

Preimplantation Genetic Testing for Aneuploidy (PGT-A) is a laboratory technique used to assess embryos for abnormalities in chromosome number before embryo transfer.

Because chromosomal abnormalities become more common with maternal age, women over 40 frequently ask whether PGT-A should be included in their IVF treatment.

PGT-A may provide useful information in selected circumstances, but it is not automatically appropriate for every patient.

For women who produce very few embryos, for example, the benefits, limitations and implications of testing require careful discussion.

The decision should therefore be made individually with the fertility specialist and embryology team.

The Importance of Sperm Quality

IVF after 40 should not focus exclusively on female age.

Sperm contributes half of the embryo’s genetic material, and male reproductive health should therefore form part of a comprehensive fertility assessment.

A semen analysis commonly evaluates parameters such as:

• Sperm concentration
• Motility
• Morphology

Depending on the couple’s reproductive history and clinical circumstances, additional male fertility evaluation may sometimes be considered.

Optimizing both female and male reproductive health provides a more complete approach than focusing solely on ovarian function.

Uterine and Endometrial Health

Producing a viable embryo is only one part of achieving pregnancy.

The embryo must also implant successfully within the uterus.

The endometrium, the inner lining of the uterus, needs to develop appropriately and provide a receptive environment for implantation.

When clinically indicated, evaluation may include endometrial thickness, uterine anatomy and investigation of conditions such as fibroids, polyps or other abnormalities that could potentially interfere with implantation.

For selected patients with persistently thin endometrium or previous implantation difficulties, additional therapeutic strategies may also be discussed.

Lifestyle and Fertility Preparation Before IVF

There is no lifestyle intervention capable of reversing reproductive aging.

However, optimizing general health before IVF is still worthwhile.

A fertility preparation strategy may include:

• Avoiding smoking
• Maintaining an appropriate body weight
• Following a balanced nutritional pattern
• Correcting identified nutritional deficiencies
• Regular appropriate physical activity
• Adequate sleep
• Managing relevant medical conditions
• Reviewing medications and supplements with the medical team

These measures should be viewed as ways of supporting overall reproductive and metabolic health—not as methods capable of making eggs biologically younger.

Can Supplements Improve IVF Success After 40?

Women preparing for IVF are frequently offered supplements marketed for “egg quality.”

Various vitamins, minerals and antioxidants have been studied in reproductive medicine, but the quality and consistency of evidence vary considerably.

No supplement can currently be guaranteed to reverse age-related changes in egg quality.

Supplementation should therefore be individualized according to medical history, nutritional status and the treatment plan rather than based on a generic fertility formula.

Importantly, women over 40 should avoid delaying fertility evaluation for several months solely to complete a supplement program.

Time itself is a significant reproductive factor at this age.

What About Fertility IV Therapy?

Some fertility programs incorporate intravenous nutritional therapy as an adjunct to conventional treatment.

At Chania Fertility Unit, individualized approaches such as Ovarian Boost IV Therapy may be considered for selected patients as part of fertility preparation.

The objective is to support nutritional adequacy, antioxidant defenses, mitochondrial function and general metabolic health before treatment.

IV therapy should, however, be regarded as supportive care.

It cannot reverse ovarian aging, guarantee better-quality eggs or replace established fertility treatment.

Ovarian Rejuvenation After 40

Regenerative reproductive medicine is an emerging field exploring whether biological approaches may influence the ovarian environment and ovarian function.

Techniques under investigation include:

• Ovarian PRP
• Enriched PRP (EnPRP)
• Exosome-based therapies
• Stem-cell-related approaches

These approaches investigate biological mechanisms involving growth factors, cellular signaling, tissue repair, vascularization and regeneration.

Women over 40, women with diminished ovarian reserve and women with previous poor ovarian response are among the patient groups for whom regenerative approaches have generated particular research interest.

However, these therapies remain emerging or investigational approaches.

They cannot be presented as proven methods for reversing ovarian aging, producing new eggs, restoring fertility or guaranteeing pregnancy.

At Chania Fertility Unit, any consideration of regenerative fertility treatment should form part of an individualized assessment rather than being viewed as an alternative to appropriate fertility evaluation or established assisted reproduction.

When Should Donor Eggs Be Considered?

For some women over 40, treatment using donor eggs may provide another pathway to pregnancy.

The decision to consider donor eggs is highly personal.

It may arise after repeated unsuccessful IVF attempts, difficulty obtaining viable embryos, very diminished ovarian reserve or when the probability of success using the patient’s own eggs has become very low.

An important biological distinction is that when donor eggs are used, the age of the egg donor rather than the age of the recipient is much more relevant to the reproductive potential of the egg.

However, the recipient’s health and ability to safely carry a pregnancy remain important.

A fertility specialist can explain the expected advantages and limitations of both own-egg and donor-egg IVF so that the patient or couple can make an informed decision.

Is 40 Too Late for IVF?

No single birthday determines whether IVF is possible.

But fertility does decline substantially with age, and this decline becomes increasingly important after 40.

The most useful question is therefore not simply:

“Am I too old for IVF?”

A better question is:

“Given my age, ovarian reserve, medical history and previous reproductive outcomes, what are my realistic treatment options now?”

That question can only be answered through individualized fertility assessment.

Why Timing Matters After 40

For a woman over 40 who wishes to become pregnant, one of the most valuable resources is time.

Months spent trying unproven treatments, supplements or methods intended to “reverse ovarian aging” can potentially reduce the reproductive opportunities available later.

Professional fertility evaluation does not mean that IVF must automatically begin immediately.

It means obtaining the information needed to understand the current reproductive situation and make informed decisions without unnecessary delay.

IVF After 40: A Personalized Path Forward

IVF after 40 is not a single treatment pathway.

Some women may be candidates for IVF using their own eggs. Others may need modified ovarian stimulation strategies. Some may consider embryo testing in appropriate circumstances, while others may eventually explore donor eggs.

Supportive fertility preparation and, for carefully selected patients, emerging regenerative approaches may also form part of the broader treatment discussion.

The key is personalization.

Age matters, but it should be considered alongside ovarian reserve, egg and sperm factors, previous reproductive history, uterine health and the patient’s individual goals.

At Chania Fertility Unit, women considering IVF after 40 can undergo a comprehensive fertility assessment to develop an individualized treatment strategy based on their reproductive profile, previous treatment history and personal priorities.

The objective is not to promise a particular outcome, but to identify the most appropriate available options and help each patient make informed decisions about her fertility journey.